Adaptin Bio (APTN) Amortization of Deferred Charges (2024 - 2025)
Adaptin Bio (APTN) reported Amortization of Deferred Charges of $53722.0 for Q1 2025, up 101.46% on a YoY basis from $26666.0 in Q1 2024, and down 50.44% sequentially from $108389.0 in Q4 2024.
Adaptin Bio (APTN) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Adaptin Bio (APTN) has 2 years of Amortization of Deferred Charges data on file, last reported at $53722.0 in Q1 2025.
- For the quarter ending Q1 2025, Amortization of Deferred Charges rose 101.46% year-over-year to $53722.0; the trailing twelve-month figure through Dec 2025 stood at $53722.0 (down 77.6% YoY), and the FY2025 full-year result was $53722.0, down 77.6% from the prior year.
- Amortization of Deferred Charges slipped to $53722.0 in Q1 2025, from $108389.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $108389.0 in Q4 2024 to a low of $22881.0 in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 53,722.00 |
| Mar 31, 2025 | 53,722.00 |
| Dec 31, 2024 | 108,389.00 |
| Dec 31, 2024 | 108,389.00 |
| Sep 30, 2024 | 81,853.00 |
| Sep 30, 2024 | 81,853.00 |
| Jun 30, 2024 | 22,881.00 |
| Jun 30, 2024 | 22,881.00 |
| Mar 31, 2024 | 26,666.00 |
| Mar 31, 2024 | 26,666.00 |